Infinium Pharmachem Ltd (INFINIUM) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Infinium Pharmachem Ltd on NSE and BSE, with an AI summary of each filing.
INFINIUM PHARMACHEM LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 06 Nov 2026, 5:30 am
Infinium Pharmachem Schedules Board Meeting on 6th Nov'26 for Half-Year Financial Results Infinium Pharmachem Limited has informed the exchange that a meeting of its Board of Directors is scheduled to be held on 6th Nov'26. The board will inter-alia consider and approve the company's unaudited financial results for the half-year ended Sep'26.
To consider and approve the half year financial results for the period ended September 30, 2026
Intimation · 06 Nov 2026, 5:30 am
Infinium Pharmachem Schedules Board Meeting on 6th Nov'26 to Consider Half-Yearly Results Infinium Pharmachem Limited has scheduled a meeting of its Board of Directors on 6th Nov'26. The primary agenda is to consider and approve the standalone and consolidated unaudited financial results of the company, along with the auditor's limited review report, for the half year ended 30th Sep'26.
Quarterly Compliance for Integrated Governance for quarter ended 30.09.2026
Others (Uncategorized) · 09 Oct 2026, 9:44 pm
Infinium Pharmachem Regulatory Filings for Quarter Ended Sep'26 Infinium Pharmachem Limited reported that Corporate Governance Report submissions under Regulation 27(2) of SEBI LODR Regulations, 2015, are not applicable for the quarter ended 30th Sep'26, citing exemptions under Regulation 15(2)(b) due to its listing on the SME exchange. Separately, Registrar and Share Transfer Agent Bigshare Services confirmed zero investor complaints were received, resolved, or pending for the period from 1st Jul'26 to 30th Sep'26.
Infinium Pharmachem Limited has informed the Exchange regarding 'Submission of Annual Secretarial Compliance Report for purpose of Migration from NSE Emerge to Main Board of NSE'.
Annual Report · 30 Sept 2026, 5:40 pm
Infinium Pharmachem Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 29 Sept 2026, 12:50 am
Infinium Pharmachem Approves Migration to NSE Mainboard via Postal Ballot Infinium Pharmachem Limited secured unanimous shareholder approval via a postal ballot concluded on 26th Sep'26 to migrate its equity shares from the NSE Emerge platform to the Mainboard of NSE. Remote e-voting saw 12,086,960 total valid votes polled (representing 77.56% of outstanding shares), with 100% cast in favor and zero dissenting votes. Excluding 9,888,460 promoter votes per SEBI ICDR Regulation 277 requirements, public shareholders cast all 2,198,500 valid votes in favor, fulfilling the requisite majority for mainboard listing.
Infinium Pharmachem Limited has informed the Exchange about Credit Rating- New
Others (Uncategorized) · 22 Sept 2026, 5:19 pm
ICRA Assigns [ICRA]BBB (Stable) Rating to Infinium Pharmachem’s Bank Facilities ICRA Limited assigned a long-term rating of [ICRA]BBB with a Stable outlook to Infinium Pharmachem Limited’s credit facilities totaling Rs 52.20 crore. The rated debt comprises Rs 45.25 crore in long-term fund-based cash credit facilities (Rs 19.00 crore from ICICI Bank and Rs 26.25 crore from State Bank of India), Rs 6.84 crore in term loans (Rs 3.72 crore from ICICI Bank and Rs 3.12 crore from State Bank of India), and Rs 0.11 crore in unallocated limits, assigned on 15th Sep'26.
Infinium Pharmachem Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 17, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 19 Sept 2026, 1:18 am
Infinium Pharmachem Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 17, 2026
Annual General Meeting · 17 Sept 2026, 9:47 pm
Infinium Pharmachem Limited has informed the Exchange about Schedule of meet
Intimation · 27 Aug 2026, 9:37 pm
Infinium Pharmachem To Host Institutional Investor Meeting and Site Visit Infinium Pharmachem has scheduled an in-person group meeting and site visit with a group of institutional investors on 03rd Sep'26. The meeting will take place at the company's factory site located at Plot 37-39 GIDC, Sojitra, Dist. Anand. The company has stated that no unpublished price-sensitive information will be shared during the interaction. The schedule is subject to change based on exigencies.
Infinium Pharmachem Limited has informed the Exchange that Record date for the purpose of MT is 10-Sep-2026.
Others · 26 Aug 2026, 8:49 pm
Infinium Pharmachem Sets Record Date for AGM E-Voting Infinium Pharmachem has fixed Thu, 10th Sep'26 as the record date to determine shareholder eligibility for remote e-voting for its Annual General Meeting (AGM). The AGM is scheduled to be held on Thu, 17th Sep'26. The announcement pertains to the financial year 2025-26. No book closure dates were specified in the filing.
Infinium Pharmachem Limited has informed the Exchange regarding Notice of Postal Ballot
Annual General Meeting · 25 Aug 2026, 10:46 pm
Infinium Pharmachem Seeks Shareholder Approval for Migration to NSE Mainboard Infinium Pharmachem has initiated a postal ballot to seek shareholder approval for migrating its equity shares from the NSE Emerge platform to the NSE Mainboard. The Board believes this move will enhance corporate reputation, improve price discovery, and increase investor participation. The remote e-voting period is scheduled from 09:00 a.m. on 28th Aug'26 to 05:00 p.m. on 26th Sep'26. The cut-off date for determining shareholder eligibility is 21st Aug'26. Voting results will be announced on or before 29th Sep'26.
Infinium Pharmachem Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 17, 2026
Annual General Meeting · 22 Aug 2026, 11:06 pm
Infinium Pharmachem Limited has informed the Exchange regarding Change in Auditors of the company.
Change in Auditor · 22 Aug 2026, 6:28 pm
Infinium Pharmachem Appoints Auditors for FY 2026-27 Infinium Pharmachem's Board of Directors has appointed three separate audit firms for FY 2026-27, effective 22 Aug'26, as recommended by its Audit Committee. Ronak R Jain & Associates, Chartered Accountants, will serve as the Internal Auditor. RTBR & Associates, Company Secretaries, have been appointed as the Secretarial Auditor. BRS & Associates, Cost Accountants, will act as the Cost Auditor. All appointments are for regulatory compliance. The appointees are firms with extensive experience in their respective domains of audit and compliance.
Infinium Pharmachem Limited has informed the Exchange regarding Outcome of Board Meeting held on August 22, 2026.
Outcome · 22 Aug 2026, 6:18 pm
Infinium Pharmachem Board Approves Migration to NSE Main Board The Infinium Pharmachem board, in its meeting on 22-Aug-'26, approved the migration of its equity shares from the NSE SME Platform to the NSE Main Board. For this migration, the company has appointed Swastika Investmart as the Merchant Banker. The board also scheduled the 22nd Annual General Meeting for 17-Sep-'26, setting 10-Sep-'26 as the record date. Additionally, the company appointed new Secretarial, Cost, and Internal auditors for FY 2026-27 and re-appointed a director, Mitesh Lavjibhai Chikhaliya.
INFINIUM PHARMACHEM LIMITED has informed the Exchange about Board Meeting to be held on 22-Aug-2026 to consider Other business.
Intimation · 14 Aug 2026, 11:36 pm
Infinium Pharmachem Board Meeting Scheduled for Other Business Infinium Pharmachem has scheduled a Board of Directors meeting for 22-Aug-26. The agenda for the meeting is to consider unspecified "Other business." Further details on the specific matters to be discussed have not been disclosed at this time.
To consider other business matters
Others (Uncategorized) · 14 Aug 2026, 11:34 pm
Infinium Pharmachem Board to Consider Migration to NSE Main Board Infinium Pharmachem's Board of Directors will meet on 22nd Aug'26 to consider migrating its listing from the NSE SME platform to the Main Board. Key agenda items also include appointing a Merchant Banker for the migration, fixing the cut-off date for the associated postal ballot, and approving the Director's report for FY26. Additionally, the board will review the re-appointment of a director, auditors for FY27, and consider the Cost Audit and Secretarial Audit reports for FY26.